Qualitative Analysis of Barriers to Consistent Use of Neuromuscular Monitoring in General Anaesthesia

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02239965

Enrollment

Registered

2014-09-15

Start date

2014-06-30

Completion date

2015-03-31

Last updated

2019-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuromuscular Blockade

Keywords

Neuromuscular blockade, Neuromuscular monitoring, Focus group interview, Clinical observation

Brief summary

Monitoring the degree of neuromuscular blockade in general anaesthesia reduces complications and patient discomfort. However, monitoring is not applied consistently by Danish anaesthesia personnel. Surveys show that part of the explanation is that the anaesthetists often experience problems with the equipment used for monitoring, though the problems have not been described in detail. We hypothesise that the lack of consistent monitoring in general anaesthesia is caused by insecurity in the anaesthesia personnel's set-up and use of the equipment, as well as in interpreting the measurement results.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* has been working in the field of anaesthesiology for at least 1 year.

Exclusion criteria

* none

Design outcomes

Primary

Measure	Time frame	Description
Description of the barriers to consistent neuromuscular monitoring, based on a qualitative analysis of focus group interviews with anaesthesiologists and nurse anaesthetists	Focus group interviews conducted Sep. - Oct. 2014 (2 months)	Focus group interviews will collect participants' perspectives and will be analyzed for thoughts, opinions, and feelings in regard to neuromuscular monitoring. Specific problems experienced with the equipment and other possible barriers to the consistent use of monitoring will be described qualitatively.

Secondary

Measure	Time frame	Description
Description of the problems experienced with neuromuscular monitoring in daily clinical practice	Clinical observations conducted in Sep. - Oct. 2014 (2 months)	The problems experienced with neuromuscular monitoring will be described through a qualitative analysis of clinical observations of the personnel's daily use of the monitoring equipment,

Countries

Denmark

Outcome results